EVDW SRL
The score of EVDW shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +34 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
EVDW's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 05 Sep 2022
EVDW's financial analysis
- Solvency59.1%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of EVDW
EVDW's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0659.858.336
- VAT number
- BE0659858336
- Peppol
- Registered · 0208:0659858336 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Jul 2016
- Registered office
- 9050 Ghent
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
EVDW (SRL) has been based in Ghent since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 72,869 € and equity of 814,592 €; its revenue is not published. Its solvency stands at 59.1%, above the median of its sector (44.0%).
Companies similar to EVDW
Companies in the same business, of comparable size and area, outside its group.
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Geerts Farma Retail sale of pharmaceutical products Vilvoorde · balance sheet €1.38m
- AD Pharma Retail sale of pharmaceutical products Châtelet · balance sheet €1.37m
- Apogrez Retail sale of pharmaceutical products Grez-Doiceau · balance sheet €1.37m
- Mast & CO Retail sale of pharmaceutical products Merchtem · balance sheet €1.36m
- Rafar Retail sale of pharmaceutical products Chimay · balance sheet €1.40m
Frequently asked questions about EVDW
What is the revenue of EVDW?
EVDW files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of EVDW?
In Belgium, the VAT number is the company number prefixed with BE: BE0659858336 for EVDW, if the company is VAT-registered. Its company number (CBE) is 0659.858.336.
Where is the registered office of EVDW?
According to the CBE register, the registered office of EVDW is in 9050 Ghent.
What is the equity of EVDW?
At the close of the 2025 financial year, the equity of EVDW amounts to 814,592 €, a solvency of 59.1% of total assets.
Who manages EVDW?
The register lists 1 active mandates at EVDW. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of EVDW
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →